BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15580298)

  • 1. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
    Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
    Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
    Mashimo T; Bandyopadhyay S; Goodarzi G; Watabe M; Pai SK; Gross SC; Watabe K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):370-6. PubMed ID: 10913345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic organization of the human KAI1 metastasis-suppressor gene.
    Dong JT; Isaacs WB; Barrett JC; Isaacs JT
    Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P; Ow K; Yardley G; Delprado W; Quinn DI; Yang JL; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(2):174-81. PubMed ID: 12806379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y; Yang JL; Markovic B; Jackson P; Yardley G; Barrett J; Russell PJ
    Clin Cancer Res; 1997 Jul; 3(7):1045-9. PubMed ID: 9815782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene.
    Gao AC; Lou W; Dong JT; Barrett JC; Danielpour D; Isaacs JT
    Prostate; 2003 Dec; 57(4):256-60. PubMed ID: 14601021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.
    Duriez C; Falette N; Cortes U; Moyret-Lalle C; Puisieux A
    Oncogene; 2000 May; 19(20):2461-4. PubMed ID: 10828889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
    Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
    Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAI1 tetraspanin and metastasis suppressor.
    Jackson P; Marreiros A; Russell PJ
    Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines.
    Jackson P; Grimm MO; Kingsley EA; Brosius U; Antalis T; Yardley G; Russell PJ
    Urol Oncol; 2002; 7(3):99-104. PubMed ID: 12474542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nectin-2 expression in testicular cells is controlled via the functional cooperation between transcription factors of the Sp1, CREB, and AP-1 families.
    Lui WY; Sze KL; Lee WM
    J Cell Physiol; 2006 Apr; 207(1):144-57. PubMed ID: 16250013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.